CRVS · Company research
Corvus Pharmaceuticals, Inc. (CRVS): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Understanding Momentum Shifts in (CRVS) - Stock Traders Daily | Understanding Momentum Shifts in (CRVS) Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 7, 2026 | neutral | 0 | 0.6 |
| One drug is now in trials for four conditions, including a skin disease. - Stock Titan | One drug is now in trials for four conditions, including a skin disease. Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| Corvus Stock: Soquelitinib Q1 Interim Futility Analysis AD Drug Advancement (NASDAQ:CRVS) - Seeking Alpha | Corvus Stock: Soquelitinib Q1 Interim Futility Analysis AD Drug Advancement (NASDAQ:CRVS) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 10, 2026 | neutral | 0 | 0.6 |
| Corvus Eczema Trial Is Expected to Enroll About 200 Patients - Stock Titan | Corvus Eczema Trial Is Expected to Enroll About 200 Patients Stock Titan | View source ↗ | Stock Titan | Aug 6, 2026 | neutral | 0 | 0.6 |
| Corvus Pharmaceuticals (CRVS) Board Resignation Puts Leadership Outlook In Focus - Simply Wall Street | Corvus Pharmaceuticals (CRVS) Board Resignation Puts Leadership Outlook In Focus Simply Wall Street | View source ↗ | Simply Wall Street | Jul 26, 2026 | neutral | 0 | 0.6 |
| CRVS Forecast — Price Target — Prediction for 2027 - TradingView | CRVS Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Corvus Pharmaceuticals Director Buys 21,700 Shares. Does This Mean CRVS a Buy? - The Motley Fool | Corvus Pharmaceuticals Director Buys 21,700 Shares. Does This Mean CRVS a Buy? The Motley Fool | View source ↗ | The Motley Fool | Jun 23, 2026 | neutral | 0 | 0.6 |
| Is Corvus Pharmaceuticals, Inc. (CRVS) A Good Stock To Buy Now? - Yahoo Finance | Is Corvus Pharmaceuticals, Inc. (CRVS) A Good Stock To Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 13, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: President and CEO of $CRVS Buys 1,932 Shares - Quiver Quantitative | Insider Purchase: President and CEO of $CRVS Buys 1,932 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | May 20, 2026 | neutral | 0 | 0.6 |
| Is It Too Late To Consider Corvus Pharmaceuticals (CRVS) After A 335% One Year Surge? - Simply Wall Street | Is It Too Late To Consider Corvus Pharmaceuticals (CRVS) After A 335% One Year Surge? Simply Wall Street | View source ↗ | Simply Wall Street | May 10, 2026 | neutral | 0 | 0.6 |
| Return To Losses And New Shelf Offering Might Change The Case For Investing In Corvus Pharmaceuticals (CRVS) - Yahoo Finance | Return To Losses And New Shelf Offering Might Change The Case For Investing In Corvus Pharmaceuticals (CRVS) Yahoo Finance | View source ↗ | Yahoo Finance | May 10, 2026 | neutral | 0 | 0.6 |
| CRVS Stock Surges 10%, Hits 50-DMA For First Time In A Month – Here’s Why Goldman Sachs Sees A 166% Upside - Stocktwits | CRVS Stock Surges 10%, Hits 50-DMA For First Time In A Month – Here’s Why Goldman Sachs Sees A 166% Upside Stocktwits | View source ↗ | Stocktwits | Apr 17, 2026 | neutral | 0 | 0.6 |
| Goldman Sachs initiates Corvus Pharmaceuticals stock with buy rating - Investing.com | Goldman Sachs initiates Corvus Pharmaceuticals stock with buy rating Investing.com | View source ↗ | Investing.com | Apr 17, 2026 | neutral | 0 | 0.6 |
| CRVS Stock Surges Pre-Market After Corvus Expands Equity Raise To $175 Million - Stocktwits | CRVS Stock Surges Pre-Market After Corvus Expands Equity Raise To $175 Million Stocktwits | View source ↗ | Stocktwits | Mar 5, 2026 | neutral | 0 | 0.6 |
| Momentum Is Just Starting for These 3 Rapid-Growth Stocks in 2026 - MarketBeat | Momentum Is Just Starting for These 3 Rapid-Growth Stocks in 2026 MarketBeat | View source ↗ | MarketBeat | Feb 2, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.